CLARINEX-D® 24 Hour
What do allergy sufferers really want?
To wake up with their symptoms under control.
CLARINEX-D® 24 hour provides powerful morning congestion
relief for moderate-to-severe patients, even after yesterday's AM dose!
CLARINEX-D® 24 hour is also the only convenient once-daily dose of time
released antihistamine/decongestant combination available on the market for use
by adults and children age 12 years and older.
CLARINEX-D® 24 hour fits into your life.
CLARINEX-D® 24 hour is well tolerated.
CLARINEX-D® 24 hour contains a nonsedating antihistamine
that does not carry any FDA precautions regarding driving or alcohol
consumption.
CLARINEX-D® 24 hour may be taken without regard to
meals.
CLARINEX-D® 24 hour uses a Gel Control system to control
the release of the pseudoephedrine component for consistent delivery. This
provides once daily 24-efficacy, which allows people to wake up with their
symptoms under control.
Due to its pseudoephedrine component, CLARINEX-D® 24 Hour
Extended Release Tablets should not be taken by patients with narrow-angle
glaucoma (abnormally high eye pressure), difficulty urinating, severe high
blood pressure, or severe heart disease, or by patients who have taken a
monoamine oxidase (MAO) inhibitor within the past fourteen (14) days. Patients
with high blood pressure; diabetes; heart disease; increased intraocular
pressure (eye pressure); thyroid, liver or kidney problems; or enlarged
prostate should check with their health care provider before taking
CLARINEX-D® 24 hour. Care should be used if CLARINEX-D® 24 hour
is taken with other antihistamines and decongestants because combined effects
on the cardiovascular system may be harmful. The most commonly reported adverse
events for CLARINEX-D® 24 hour Extended Release Tablets were dry mouth,
headache, insomnia, fatigue, sore throat, and drowsiness.
CLARINEX®, a prescription medication, treats year-round allergy symptoms and ongoing hives of unknown cause, in adults and children 6 months and older, and seasonal allergy symptoms in patients 2 years and older. CLARINEX® 5 mg Tablets and 5 mg RediTabs® Tablets are approved for patients 12 years and older; CLARINEX® 2.5 mg RediTabs® Tablets are approved for patients 6 to 11 years; CLARINEX® Syrup is approved for patients 6 months and older.
Twice-daily CLARINEX-D® 12 HOUR Extended Release Tablets and once-daily CLARINEX-D® 24 HOUR Extended Release Tablets treat the symptoms of seasonal allergies, including nasal congestion, in patients 12 years and older.
IMPORTANT SAFETY INFORMATION
CLARINEX® Tablets side effects in patients 12 years and older were similar to placebo and included sore throat, dry mouth, and fatigue for seasonal and year-round allergy patients, and headache, nausea, and fatigue for patients with ongoing hives of unknown cause.
CLARINEX® Syrup side effects in children 6 to 11 years were similar to placebo. For children 6 months to 5 years, syrup side effects varied by age and included fever, diarrhea, upper respiratory infection, irritability, and coughing.
Due to their pseudoephedrine component, CLARINEX-D® 12 HOUR Extended Release Tablets and CLARINEX-D® 24 HOUR Extended Release Tablets should not be taken by patients with narrow-angle glaucoma (abnormally high eye pressure), difficulty urinating, severe high blood pressure, or severe heart disease, or by patients who have taken a monoamine oxidase (MAO) inhibitor within the past fourteen (14) days. Patients with high blood pressure; diabetes; heart disease; increased intraocular pressure (eye pressure); thyroid, liver or kidney problems; or enlarged prostate should check with their healthcare provider before taking CLARINEX-D® 12 HOUR Extended Release Tablets or CLARINEX-D® 24 HOUR Extended Release Tablets.
Care should be used if CLARINEX-D® 12 HOUR Extended Release Tablets or CLARINEX-D® 24 HOUR Extended Release Tablets are taken with other antihistamines or decongestants because combined effects on the cardiovascular system may be harmful. The most commonly reported adverse events for CLARINEX-D® 12 HOUR Extended Release Tablets were insomnia, headache, dry mouth, fatigue, drowsiness, sore throat, and dizziness. The most commonly reported adverse events for CLARINEX-D® 24 HOUR Extended Release Tablets were dry mouth, headache, insomnia, fatigue, sore throat, and drowsiness.
Click here for important CLARINEX® Tablets/Syrup/RediTabs® Product Information.
Click here for important CLARINEX-D® 12 HOUR Product Information.
Click here for important CLARINEX-D® 24 HOUR Product Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Note: The information on this site is not intended to be a substitute for professional medical advice. If you have any questions about your treatment or medical condition, please consult your doctor or other qualified health care provider. This site is intended for use by U.S. residents.
